Diagnosis and treatment for heart failure are complex task, starting from careful patients encounters, investigations and treatment decisions. ACE-Is, ARB, beta blockers and
aldosterone antagonists are the mainstay in the therapy. These drugs are proved by many trials to have benefit on reversing the core neurohormonal mechanisms of HF and also
improve long term survival. But in an acute decompensated HF, only the symptomatic treatment should be started before a more definite one. Any co-morbidity presenting with HF will result in poor prognosis. Detailed treatment of
ischemic heart disease, arrhythmias, hypertension, diabetes mellitus, valvulopathy, chronic obstructive pulmonary disease, renal failure and thromboembolism are beyond the scope of this thesis.egységes, osztatlanáltalános orvosango
